Free shipping on orders over $99*

Order before April 14th to ensure shipping before the Passover holiday. 
Shipping will be limited between April 16-30th
Tel: 1-866-456-3768  Fax: 1-866-544-8993





Prescription Required

Mounjaro is prescribed for glycemic control of adult patients with type 2 diabetes.   Each order comes with 4 vials of medication and syringes for injection, for a total of 4 weeks use.  **Special Order** Please order early as it can take up to 10 days to receive stock.

** 7.5mg-15mg are Currently out of stock – expected back in stock end of April 2024**

The cost for 4 vials (28 days supply) is $750

Place your order

Mounjaro Brand 5mg
4 Vials
Our price: $750.00
Mounjaro Brand 2.5mg
4 Vials
Our price: $750.00

*Please note all prices are in US dollars
Mounjaro (generic name: tirzepatide) is an injectable prescription medicine that is used to treat adults with type 2 diabetes. It is prescribed along with diet and exercise to improve control of blood sugar levels. Mounjaro is widely used thanks to its efficacy and safety as a single therapy or with other diabetes medicines. Tirzepatide (GIP/GLP-1RA) is a single molecule combining glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1RA). It activates the secretion of GIP and GLP-1 receptors from the intestines on ingestion of glucose or nutrients, which in turn stimulates insulin secretion from pancreatic β cells.  It also is active in regions of the brain that regulate food intake. Tirzepatide slows down the emptying of the stomach after eating, leaving people feeling full for longer and suppressing appetite. Mounjaro is not for use in people with type 1 diabetes. While there is no cure for diabetes, it was found in studies of Mounjaro that after 52 weeks,  when administered both with or without other diabetes medications, 75% to 90% of patients with an average starting HbA1C of 7.9% to 8.6% reached an HbA1C of less than 7%. Mounjaro is also effective to help with body weight reduction and was approved by the FDA for this putpose in November 2023.  In studies, weight loss in adults ranged from 12 lb (5 kg) to 25 lb (10 kg). The results in studies where candidates received tirzepatide surpass trials of other GLP-1 agonists. Mounjaro can be prescribed for patients classified as overweight (BMI of 27 – 29.9 with at least one weight-related comorbid condition, such as dyslipidemia, hypertension, obstructive sleep apnea, or cardiovascular disease) or obese (BMI greater than 30)


Mounjaro comes in single-dose vials with syringes for subcutaneous injection. It should be administered once each week on the same day of the week and at approximately the same time of day. It must injected in rotation in either the abdomen, thigh, or upper arm by choosing a different site each week. If a dose is missed, it can be made up for within three days, but beyond that, the dose must be skipped and the routine dose taken on the due date. Do not take two doses of Mounjaro within 72 hours of each other and if it is necessary to change the day, make sure there are at least 72 hours in between doses. If taking insulin and Mounjaro simultaneously, do not inject them close together in the same area.  Carefully read the information and follow instructions on the manufacturer Eli Lilly and Company’s Product Insert leaflet that comes with the medication to ensure safe usage. Watch a step-by-step video on how to use Mounjaro. We cannot be held liable for any harm caused by incorrect usage. 

Some of the most common side effects of Mounjaro are:

  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Indigestion
  • Stomach pain.

If these persist or worsen, consult with a healthcare provider.

Most nausea, vomiting, and diarrhea events occurred while the dose of Mounjaro was being increased and this decreased over time.

Please note that not all possible side effects can be listed. If any of these or other unexpected side effects are experienced, seek medical attention promptly. 


For people who have kidney problems, side effects like diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important to drink fluids to help reduce any chance of dehydration.

Gallbladder problems have been reported by some people using Mounjaro. Tell a healthcare provider right away if  symptoms of gallbladder problems appear, which may include pain in the  upper abdomen, fever, yellowing of skin or eyes (jaundice), and clay-colored stools.

Mounjaro may cause tumors in the thyroid, including thyroid cancer. Watch for possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.

  • Do not use Mounjaro if you or any member of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).
  • Do not use Mounjaro if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Do not use Mounjaro if you are allergic to it or any of the ingredients in Mounjaro.


Mounjaro may cause serious side effects, including:

  • Inflammation of the pancreas (pancreatitis). Stop using Mounjaro and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.
  • Serious allergic reactions. Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.
  • Changes in vision. Tell your healthcare provider if you have changes in vision during treatment with Mounjaro.

Mounjaro (combining GIP and GLP-1 receptor agonists) treats adults with type 2 diabetes, but is not for type 1 diabetes. It has not yet been approved for children under the age of 16.

The drug can lower blood sugar levels, but is not a cure for diabetes. Do not stop taking Mounjaro without consulting with a doctor.

Tirzepatide, under the brand name Zepbound, can also be prescribed for patients who are overweight with ancilliary problems such as dyslipidemia, hypertension, obstructive sleep apnea, or cardiovascular disease, and for people who are obese (BMI higher than 30).


  • What should be done if a dose of Mounjaro is missed?
    You can take the dose within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and take the next dose on the regularly scheduled day. Do not take 2 doses of Mounjaro within 3 days of each other.
  • What should be done in case of overdose of Mounjaro?
    The risk of getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Symptoms of hypoglycemia may include dizziness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes. Consult immediately with a healthcare provider or go to an emergency care center.
  • Can I travel with Mounjaro pens?
    If traveling, Mounjaro pens in their original carton can be kept for up to 21 days outside of the refrigerator as long as the temperature doesn’t go higher than 86°F (30°C).
  • Can Mounjaro produce weight loss?
    Tirzepatide can works in several ways to promote weight loss. GIP/GLP-1RA molecules slow down the emptying of the stomach and inhibit hunger, which can suppress appetite. People being treated feel satiated for longer after meals and therefore eat less. After extensive peer reviewed clinical trials in which tirzepatide compared to other options, it has been approved by the FDA as a weight loss drug and will be marketed under the brand name Zepbound.

Getting started with IsraelPharm


Send Your Prescription

Secure Payment

No Hidden Fees

Fast Shipping

Generally 7-10 Business Days

Ordering is
simple and safe.

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.

Read more from our blog

National Osteoporosis Awareness and Prevention Month

May is National Osteoporosis Awareness and Prevention Month

National Osteoporosis Awareness and Prevention Month, observed each year in May, is dedicated to educating the public and raising awareness of the importance of osteoporosis prevention, screening, and treatment. The Bone Health and Osteoporosis Foundation


Fast Delivery
Ships from Israel
Secure Payment
Genuine Brands
Pharmacist Oversight
Proudly Israeli
Free Shipping on orders over $99*

Having issues?

Daily from 9am-8pm EST.
IsraelPharm c/o SUBS Ltd. Ha'Uman 5 Bet Shemesh Israel, 9906105

Sign up for $10 off your first order!

Enjoy exclusive deals we only share via email